Table 2.
Hematological parameters associated with in-hospital mortality
| Variable | Survivors n = 229 |
Non-survivors n = 49 |
p§ |
|---|---|---|---|
| Median (IQR) | Median (IQR) | ||
| WBC, *103/µL | 11 (7.2–15.2) | 12.9 (6.8–17.1) | 0.53 |
| Neutrophils, *103/µL | 8.7 (4.9–13) | 10.6 (6.4–15.5) | 0.20 |
| Lymphocytes, *103/µL | 1.1 (0.6–1.6) | 0.60 (0.3–1.1) | < 0.001 |
| Monocytes, *103/µL | 0.7 (0.4–0.9) | 0.5 (0.2–0.9) | 0.002 |
| Platelet, *103/µL | 192 (138–262) | 154 (74–229) | 0.003 |
| CD3 + T Lymphocytes, cells/µL | 673 (368–1,080) | 347 (188–536) | < 0.001 |
| CD4 + T Lymphocytes, cells/µL | 405 (222–661) | 197 (106–265) | < 0.001 |
| CD8 + T Lymphocytes, cells/µL | 268 (133–461) | 134 (87–231) | < 0.001 |
| CD16/56 + Lymphocytes, cells/µL | 34 (14–91) | 37 (16–106) | 0.66 |
| CD19 + B Lymphocytes, cells/µL | 130 (67–227) | 76 (35–140) | < 0.001 |
WBC white blood cell count, IQR interquartile range
§Calculated with Kruskal–Wallis